Literature DB >> 21679792

The newer fluoroquinolones.

Maureen K Bolon1.   

Abstract

Clinicians have enthusiastically used fluoroquinolones owing to their good safety profile and wide range of indications. This article reviews fluoroquinolone pharmacology, pharmacodynamic principles, and fluoroquinolone resistance mechanisms, highlighting recent trends in the epidemiology of fluoroquinolone resistance among gram-negative organisms and Streptococcus pneumonia. Important fluoroquinolone safety concerns are discussed, along with indications for the most commonly used fluoroquinolones--ciprofloxacin, levofloxacin, and moxifloxacin.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Year:  2011        PMID： 21679792     DOI： 10.1016/j.mcna.2011.03.006

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


  10 in total

1.  Simultaneous Semimechanistic Population Analyses of Levofloxacin in Plasma, Lung, and Prostate To Describe the Influence of Efflux Transporters on Drug Distribution following Intravenous and Intratracheal Administration.

Authors:  Estevan Sonego Zimmermann; João Victor Laureano; Camila Neris Dos Santos; Stephan Schmidt; Chakradhar V Lagishetty; Whocely Victor de Castro; Teresa Dalla Costa
Journal:  Antimicrob Agents Chemother       Date:  2015-11-30       Impact factor: 5.191

Review 2.  Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review.

Authors:  M C Gaspar; W Couet; J-C Olivier; A A C C Pais; J J S Sousa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-26       Impact factor: 3.267

3.  Dual Glycation-Inflammation Modulation, DPP-IV and Pancraetic Lipase Inhibitory Potentials and Antiproliferative Activity of Novel Fluoroquinolones.

Authors:  Shereen Arabiyat; Violet Kasabri; Yusuf Al-Hiari; Ihab Al-Masri; Sundus Alalawi; Yasser Bustanji
Journal:  Asian Pac J Cancer Prev       Date:  2019-08-01

4.  Thiosemicarbazide Derivatives Decrease the ATPase Activity of Staphylococcus aureus Topoisomerase IV, Inhibit Mycobacterial Growth, and Affect Replication in Mycobacterium smegmatis.

Authors:  Aleksandra Kowalczyk; Agata Paneth; Damian Trojanowski; Piotr Paneth; Jolanta Zakrzewska-Czerwińska; Paweł Stączek
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

5.  Systemic quinolones and risk of retinal detachment III: a nested case-control study using a US electronic health records database.

Authors:  Mohamed Kadry Taher; James A G Crispo; Yannick Fortin; Ryan Moog; Douglas McNair; Lise M Bjerre; Franco Momoli; Donald Mattison; Daniel Krewski
Journal:  Eur J Clin Pharmacol       Date:  2022-03-15       Impact factor: 3.064

6.  Molecular characteristics of fluoroquinolone-resistant Escherichia coli isolated from suckling piglets with colibacillosis.

Authors:  Kwangwon Seo; Kyung-Hyo Do; Wan-Kyu Lee
Journal:  BMC Microbiol       Date:  2022-09-15       Impact factor: 4.465

7.  In Vitro Comparison of Antibacterial and Antibiofilm Activities of Selected Fluoroquinolones against Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus.

Authors:  Majed M Masadeh; Karem H Alzoubi; Wesam S Ahmed; Aisha S Magaji
Journal:  Pathogens       Date:  2019-01-24

8.  An sRNA Screen for Reversal of Quinolone Resistance in Escherichia coli.

Authors:  Kamya Bhatnagar; Aaron Hinz; Melissa Kohlman; Alex Wong
Journal:  G3 (Bethesda)       Date:  2020-01-07       Impact factor: 3.154

9.  Systemic quinolones and risk of acute liver failure III: A nested case-control study using a US electronic health records database.

Authors:  Mohamed Kadry Taher; James A G Crispo; Yannick Fortin; Ryan Moog; Douglas McNair; Lise M Bjerre; Franco Momoli; Donald Mattison; Daniel Krewski
Journal:  J Gastroenterol Hepatol       Date:  2021-03-31       Impact factor: 4.029

10.  Systemic quinolones and risk of acute liver failure I: Analysis of data from the US FDA adverse event reporting system.

Authors:  Mohamed Kadry Taher; Abdallah Alami; Christopher A Gravel; Derek Tsui; Lise M Bjerre; Franco Momoli; Donald R Mattison; Daniel Krewski
Journal:  JGH Open       Date:  2021-06-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.